Annual report pursuant to Section 13 and 15(d)

Selected Quarterly Financial Data (Tables)

v3.3.1.900
Selected Quarterly Financial Data (Tables)
12 Months Ended
Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Data

Quarterly financial information for fiscal 2015 and 2014 are presented in the following table, in thousands, except per share data:

 

 

 

For the Quarter Ending

 

 

 

March 31

 

 

June 30

 

 

September 30

 

 

December 31

 

2015:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lymphoseek sales revenue

 

$

1,835

 

 

$

1,964

 

 

$

2,953

 

 

$

3,503

 

Lymphoseek license revenue

 

 

83

 

 

 

250

 

 

 

550

 

 

 

250

 

Grant and other revenue

 

 

190

 

 

 

654

 

 

 

477

 

 

 

541

 

Gross profit

 

 

1,659

 

 

 

2,535

 

 

 

3,522

 

 

 

3,778

 

Operating expenses

 

 

9,475

 

 

 

6,346

 

 

 

7,845

 

 

 

6,379

 

Operating loss

 

 

(7,816

)

 

 

(3,811

)

 

 

(4,323

)

 

 

(2,601

)

Net loss attributable to common stockholders

 

 

(7,337

)

 

 

(9,691

)

 

 

(8,071

)

 

 

(2,510

)

Basic and diluted net loss per share (1)

 

$

(0.05

)

 

$

(0.06

)

 

$

(0.05

)

 

$

(0.02

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lymphoseek sales revenue

 

$

627

 

 

$

1,046

 

 

$

1,101

 

 

$

1,460

 

Lymphoseek license revenue

 

 

 

 

 

 

 

 

300

 

 

 

 

Grant and other revenue

 

 

125

 

 

 

28

 

 

 

849

 

 

 

738

 

Gross profit

 

 

559

 

 

 

804

 

 

 

1,442

 

 

 

1,884

 

Operating expenses

 

 

9,138

 

 

 

10,020

 

 

 

6,805

 

 

 

6,360

 

Operating loss

 

 

(8,579

)

 

 

(9,216

)

 

 

(5,363

)

 

 

(4,476

)

Net loss attributable to common stockholders

 

 

(11,741

)

 

 

(10,222

)

 

 

(6,899

)

 

 

(6,865

)

Basic and diluted net loss per share (1)

 

$

(0.08

)

 

$

(0.07

)

 

$

(0.05

)

 

$

(0.05

)

 

 

(1)

Net loss per share is computed independently for each of the quarters presented. Therefore the sum of the quarterly per-share calculations will not necessarily equal the annual per share calculation.